SecProbe.io

Stored correspondence activity detail
Intelligence Terminal Search Topics Monthly Activity About

Correspondence Activity Detail

PALISADE BIO, INC. (PALI)
Activity window: Sep. 25, 2025 to Sep. 24, 2026

Correspondence Filings
2
Keyword Matches
0
Latest Activity
Sep. 29, 2025
Related 8-Ks
0

Matched Signals

No stored keyword or signal matches were recorded for this activity window.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
May. 19, 2026 UPLOAD Neutral/Informational Low The SEC correspondence dated May 19, 2026, informs J.D. Finley, CEO of Palisade Bio, Inc., that the SEC will not review their registration statement filed on May 12, 2026. The let… Read Filing EDGAR
May. 19, 2026 CORRESP Neutral/Informational Moderate Palisade Bio, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-3, which was filed on May 12, 2026. They are seeking to have t… Read Filing EDGAR
Sep. 29, 2025 CORRESP Neutral/Informational High Palisade Bio, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1, originally filed on September 29, 202… Read Filing EDGAR
Sep. 29, 2025 CORRESP Neutral/Informational Moderate The correspondence from Ladenburg Thalmann & Co. Inc. indicates their concurrence with Palisade Bio, Inc.'s request to accelerate the effective date of their registration statemen… Read Filing EDGAR
Sep. 29, 2025 CORRESP Neutral/Informational Moderate Palisade Bio, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1, which was filed on September 29, 2025… Read Filing EDGAR
Sep. 29, 2025 CORRESP Neutral/Informational Low Palisade Bio, Inc. submitted a response to the SEC regarding comments on their Draft Registration Statement on Form S-1. The SEC had raised questions about the exercise provisions… Read Filing EDGAR
Sep. 29, 2025 CORRESP Neutral/Informational Moderate The correspondence from Ladenburg Thalmann & Co. Inc. to the SEC indicates their concurrence with Palisade Bio, Inc.'s request to accelerate the effective date of their registrati… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in this activity window.